Maxim analyst Jason McCarthy upgraded Dare Bioscience (DARE) to Buy from Hold with an $8 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DARE:
- Daré Bioscience Engages Market with New Presentation
- Daré Bioscience’s Earnings Call: Optimism Amid Challenges
- Daré Bioscience: Strategic Growth and Market Expansion with Upcoming Sildenafil Cream Launch
- Daré Bioscience Announces Q2 2025 Financial Results
- Dare Bioscience, Rosy Wellness launch first phase to support DARE to PLAY